Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q1

8129.TEDINET S100RNXE
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥351.2bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥1.39T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥324.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥2.3bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥2.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥19.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥2.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥3.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥734.5bnat 2023-06-30Cons.Assets
Total assets¥715.3bnat 2023-03-31Cons.Assets
Total assets¥710.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥493.4bnat 2023-06-30Cons.Liabilities
Total liabilities¥472.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥241.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥242.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥243.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥92.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥86.2bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥23.072023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥196.72022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.222022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥21.122023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥180.672022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio32.8%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥14.9bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥14.9bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥810m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2023-04-01 → 2023-06-30¥22.8bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2023-04-01 → 2023-06-30¥22.8bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2023-04-01 → 2023-06-30¥112m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2023-04-01 → 2023-06-30¥2.7bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2023-04-01 → 2023-06-30¥608m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥2.0bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2023-04-01 → 2023-06-30¥293m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2023-04-01 → 2023-06-30¥339.1bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2023-04-01 → 2023-06-30¥326.6bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥12.5bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.1bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥338m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥35m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥366.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥351.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥14.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥401m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥133m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-06-30¥612m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-06-30¥288m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-06-30¥312.7bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-06-30¥300.3bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥356m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥94m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥338.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥324.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥2.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 417
ItemContextValueUnit
Other noiPrior1YTDDuration327000000JPY
Other noiCurrentYTDDuration172000000JPY
Non operating incomePrior1YTDDuration1048000000JPY
Non operating incomeCurrentYTDDuration897000000JPY
Interest expenses noePrior1YTDDuration20000000JPY
Interest expenses noeCurrentYTDDuration15000000JPY
Equity in losses of affiliates noePrior1YTDDuration67000000JPY
Equity in losses of affiliates noeCurrentYTDDuration－JPY
Bond issuance cost noePrior1YTDDuration－JPY
Bond issuance cost noeCurrentYTDDuration83000000JPY
Other noePrior1YTDDuration84000000JPY
Other noeCurrentYTDDuration131000000JPY
Non operating expensesPrior1YTDDuration172000000JPY
Non operating expensesCurrentYTDDuration230000000JPY
Ordinary incomePrior1YTDDuration3142000000JPY
Ordinary incomeCurrentYTDDuration2521000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration64000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration18000000JPY
Gain on liquidation of investment securities eiPrior1YTDDuration16000000JPY
Gain on liquidation of investment securities eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration80000000JPY
Extraordinary incomeCurrentYTDDuration18000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration6000000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration41000000JPY
Impairment loss elPrior1YTDDuration19000000JPY
Impairment loss elCurrentYTDDuration－JPY
Other elPrior1YTDDuration173000000JPY
Other elCurrentYTDDuration5000000JPY
Extraordinary lossPrior1YTDDuration200000000JPY
Extraordinary lossCurrentYTDDuration47000000JPY
Income before income taxesPrior1YTDDuration3023000000JPY
Income before income taxesCurrentYTDDuration2492000000JPY
Income taxes currentPrior1YTDDuration1799000000JPY
Income taxes currentCurrentYTDDuration1706000000JPY
Income taxes deferredPrior1YTDDuration-845000000JPY
Income taxes deferredCurrentYTDDuration-746000000JPY
Income taxesPrior1YTDDuration953000000JPY
Income taxesCurrentYTDDuration959000000JPY
Profit lossPrior1YTDDuration2069000000JPY
Profit lossCurrentYTDDuration1533000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration8000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration3000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2061000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1529000000JPY
Profit lossPrior1YTDDuration2069000000JPY
Profit lossCurrentYTDDuration1533000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1467000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration3662000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass